Publication | Open Access

Preliminary safety and efficacy of first-line pertuzumab combined with trastuzumab and taxane therapy for HER2-positive locally recurrent or metastatic breast cancer (PERUSE)

Metastatic Breast CancerBreast OncologyMedicinePathologyPreliminary SafetyBreast CancerCancer TreatmentOncologyRadiation OncologyTaxane Therapy